NEXGEL (NXGLW) Competitors $0.32 +0.01 (+4.73%) As of 08/27/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock NXGLW vs. DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, LUCYW, IINNW, NVACW, and NTRBWShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), NorthView Acquisition (NVACW), and Nutriband (NTRBW). These companies are all part of the "medical equipment" industry. NEXGEL vs. Its Competitors Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NorthView Acquisition Nutriband NEXGEL (NASDAQ:NXGLW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability, media sentiment and institutional ownership. Which has stronger earnings and valuation, NXGLW or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNEXGEL$11.67MN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A Is NXGLW or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets NEXGELN/A N/A N/A Alpha Tau Medical N/A N/A N/A Does the media favor NXGLW or DRTSW? In the previous week, NEXGEL and NEXGEL both had 1 articles in the media. NEXGEL's average media sentiment score of 1.87 equaled Alpha Tau Medical'saverage media sentiment score. Company Overall Sentiment NEXGEL Very Positive Alpha Tau Medical Very Positive SummaryNEXGEL beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGLW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGLW vs. The Competition Export to ExcelMetricNEXGELMedical Instruments & Supplies IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.14B$5.76B$9.84BDividend YieldN/A1.99%3.95%4.02%P/E RatioN/A17.4131.3126.60Price / SalesN/A292.16461.30121.37Price / CashN/A146.5437.7659.36Price / BookN/A2.2510.026.67Net IncomeN/A$99.80M$3.27B$265.59M7 Day Performance6.33%0.13%3.17%3.42%1 Month Performance6.33%-1.42%4.34%1.09%1 Year Performance-36.20%116.46%44.11%23.85% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLWNEXGELN/A$0.32+4.7%N/A-38.7%$0.00$11.67M0.0010Positive NewsDRTSWAlpha Tau MedicalN/A$0.30+1.7%N/A+47.0%$0.00N/A0.0080ANZUWAnzu Special Acquisition Corp IN/A$0.04-15.3%N/A-55.0%$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.02+18.5%N/A-50.6%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79-28.1%N/AN/A$0.00N/A0.002Gap DownHSCSWHeart Test LaboratoriesN/A$0.06+0.5%N/AN/A$0.00$4.35K0.0010Positive NewsBEATWHeartBeamN/A$0.30+0.1%N/A-29.8%$0.00N/A0.005Positive NewsGap DownLUCYWInnovative EyewearN/A$0.09-2.7%N/A+99.8%$0.00$1.98M0.009Positive NewsIINNWInspira Technologies Oxy B.H.N.N/A$0.37+13.3%N/A-1.2%$0.00N/A0.0020Positive NewsGap UpNVACWNorthView AcquisitionN/A$0.14flatN/AN/A$0.00N/A0.002NTRBWNutribandN/A$1.50-1.5%N/A+2.9%$0.00$2.40M0.0010Positive News Related Companies and Tools Related Companies Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Heart Test Laboratories Alternatives HeartBeam Alternatives Innovative Eyewear Alternatives Inspira Technologies Oxy B.H.N. Alternatives NorthView Acquisition Alternatives Nutriband Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGLW) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access